Investor Alert

New York Markets Open in:

Company Close Updates

Dec. 2, 2021, 4:31 p.m. EST

Moderna Inc. stock falls Thursday, underperforms market

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) shed 2.94% to $301.49 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) rising 0.83% to 15,381.32 and the Dow Jones Industrial Average (DOW:DJIA) rising 1.82% to 34,639.79. This was the stock's third consecutive day of losses. Moderna Inc. closed $196.00 short of its 52-week high ($497.49), which the company achieved on August 10th.

The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (NYS:ABBV) rose 0.83% to $116.87, Amgen Inc. (NAS:AMGN) rose 0.18% to $201.17, and AstraZeneca PLC ADR (NAS:AZN) fell 0.16% to $54.79. Trading volume (15.3 M) eclipsed its 50-day average volume of 13.2 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.